PlumX Metrics
Embed PlumX Metrics

Chemical Genetic Screening for Compounds That Preferentially Inhibit Growth of Methylthioadenosine Phosphorylase (MTAP)–Deficient Saccharomyces cerevisiae

SLAS Discovery, ISSN: 2472-5552, Vol: 16, Issue: 1, Page: 44-52
2011
  • 6
    Citations
  • 0
    Usage
  • 18
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Methylthioadenosine phosphorylase (MTAP), a key enzyme in the methionine salvage pathway, is inactivated in a variety of human cancers. Since all human tissues express MTAP, it would be of potential interest to identify compounds that selectively inhibit the growth of MTAP-deficient cells. To determine if MTAP inactivation could be targeted, the authors have performed a differential chemical genetic screen in isogenic MTAP + and MTAP – Saccharomyces cerevisiae. A low molecular weight compound library containing 30,080 unique compounds was screened for those that selectively inhibit growth of MTAP – yeast using a differential growth assay. One compound, containing a 1,3,4-thiadiazine ring, repeatedly showed a differential dose response, with MTAP – cells exhibiting a 4-fold shift in IC 50 compared to MTAP + cells. Several structurally related derivatives of this compound also showed enhanced growth inhibition in MTAP – yeast. These compounds were also examined for growth inhibition of isogenic MTAP + and MTAP – HT1080 fibrosarcoma cells, and 4 of the 5 compounds exhibited evidence of modest but significant increased potency in MTAP – cells. In summary, these studies show the feasibility of differential growth screening technology and have identified a novel class of compounds that can preferentially inhibit growth of MTAP – cells.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know